Target intelligence / Profile preview

Fas binding factor 1 (FBF1)

Target
FBF1
Molecular classification
Other (keratin-binding protein, cytoskeleton-associated)
01

Overview

Fas binding factor 1 (FBF1) is a keratin-binding protein essential for the assembly of apical junctions and establishment of epithelial cell polarity in humans[1][10]. It is located at the apical junction complex and interacts with proteins such as PARD3 to mediate these effects[10][1]. FBF1 also plays a critical role in ciliogenesis by being part of the ciliary transition fiber, contributing to the assembly of cilia in epithelial cells[1][3][10]. Mutations in the FBF1 gene are associated with developmental disorders such as hydrolethalus syndrome[1]. FBF1 is not classified as a receptor, enzyme, transporter, or major therapeutic target, so it is not directly associated with known drug interactions or mechanisms of pharmacological intervention. The submitted query also mentions several alternative forms or synonyms (such as ALB, protein albatross, FBF-1). Some of these, like "ALB," can ambiguously refer to unrelated proteins (such as albumin), which is not related biologically to FBF1. FBF1 should not be confused with Fas-associated factor 1 (FAF1), which is a distinct protein involved in apoptotic signaling and part of the Fas-death-inducing signaling complex[2][4][8]. FBF1’s role is structural and regulatory in epithelial and ciliary biology, not in Fas-mediated apoptosis pathways[1][3][10].

Other names
Fas binding factor 1FBF1ALBKIAA1863FBF-1FLJ00103Albatrossprotein albatross
02

Biological functions

Apical junction assemblyEpithelial cell polarityCilium assemblyCiliogenesisKeratin binding
03

Disease associations

Hydrolethalus syndromeHydrolethalus syndrome 1

Beyond the preview

Go deeper on Fas binding factor 1 (FBF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fas binding factor 1 (FBF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call